Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study

PHASE3CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

December 18, 2015

Primary Completion Date

March 29, 2019

Study Completion Date

March 29, 2019

Conditions
Vascular InflammationAtherosclerotic Cardiovascular Disease
Interventions
DRUG

Low dose methotrexate

Study participants will additionally receive 1 mg daily oral folate.

DRUG

Placebo

Trial Locations (3)

10029

Icahn School of Medicine at Mount Sinai, New York

02199

Massachusetts General Hospital, Boston

Unknown

St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Brigham and Women's Hospital

OTHER

collaborator

Massachusetts General Hospital

OTHER

collaborator

Unity Health Toronto

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Icahn School of Medicine at Mount Sinai

OTHER

NCT02576067 - Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study | Biotech Hunter | Biotech Hunter